CSRNP2 and nonpapillary renal cell carcinoma: Meanwhile, although we did not find a significant effect of CSRNP2 on ccRCC OS in the entire group, we found that CSRNP2 was a remarkable hazard factor in patients with a high-, but not with a low-mutant burden (Figures 5C, F).